Cargando…
The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant Activity
Mitochondrial division inhibitor-1 (mdivi-1), a non-specific inhibitor of Drp1-dependent mitochondrial fission, is neuroprotective in numerous preclinical disease models. These include rodent models of Alzheimer’s disease and ischemic or traumatic brain injury. Among its Drp1-independent actions, th...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944504/ https://www.ncbi.nlm.nih.gov/pubmed/35326100 http://dx.doi.org/10.3390/antiox11030450 |
_version_ | 1784673730972090368 |
---|---|
author | Bordt, Evan A. Zhang, Naibo Waddell, Jaylyn Polster, Brian M. |
author_facet | Bordt, Evan A. Zhang, Naibo Waddell, Jaylyn Polster, Brian M. |
author_sort | Bordt, Evan A. |
collection | PubMed |
description | Mitochondrial division inhibitor-1 (mdivi-1), a non-specific inhibitor of Drp1-dependent mitochondrial fission, is neuroprotective in numerous preclinical disease models. These include rodent models of Alzheimer’s disease and ischemic or traumatic brain injury. Among its Drp1-independent actions, the compound was found to suppress mitochondrial Complex I-dependent respiration but with less resultant mitochondrial reactive oxygen species (ROS) emission compared with the classical Complex I inhibitor rotenone. We employed two different methods of quantifying Trolox-equivalent antioxidant capacity (TEAC) to test the prediction that mdivi-1 can directly scavenge free radicals. Mdivi-1 exhibited moderate antioxidant activity in the 2,2′-azinobis (3-ethylbenzothiazoline 6-sulfonate) (ABTS) assay. Half-maximal ABTS radical depletion was observed at ~25 μM mdivi-1, equivalent to that achieved by ~12.5 μM Trolox. Mdivi-1 also showed antioxidant activity in the α, α-diphenyl-β-picrylhydrazyl (DPPH) assay. However, mdivi-1 exhibited a reduced capacity to deplete the DPPH radical, which has a more sterically hindered radical site compared with ABTS, with 25 μM mdivi-1 displaying only 0.8 μM Trolox equivalency. Both assays indicate that mdivi-1 possesses biochemical antioxidant activity but with modest potency relative to the vitamin E analog Trolox. Future studies are needed to evaluate whether the ability of mdivi-1 to directly scavenge free radicals contributes to its mechanisms of neuroprotection. |
format | Online Article Text |
id | pubmed-8944504 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89445042022-03-25 The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant Activity Bordt, Evan A. Zhang, Naibo Waddell, Jaylyn Polster, Brian M. Antioxidants (Basel) Communication Mitochondrial division inhibitor-1 (mdivi-1), a non-specific inhibitor of Drp1-dependent mitochondrial fission, is neuroprotective in numerous preclinical disease models. These include rodent models of Alzheimer’s disease and ischemic or traumatic brain injury. Among its Drp1-independent actions, the compound was found to suppress mitochondrial Complex I-dependent respiration but with less resultant mitochondrial reactive oxygen species (ROS) emission compared with the classical Complex I inhibitor rotenone. We employed two different methods of quantifying Trolox-equivalent antioxidant capacity (TEAC) to test the prediction that mdivi-1 can directly scavenge free radicals. Mdivi-1 exhibited moderate antioxidant activity in the 2,2′-azinobis (3-ethylbenzothiazoline 6-sulfonate) (ABTS) assay. Half-maximal ABTS radical depletion was observed at ~25 μM mdivi-1, equivalent to that achieved by ~12.5 μM Trolox. Mdivi-1 also showed antioxidant activity in the α, α-diphenyl-β-picrylhydrazyl (DPPH) assay. However, mdivi-1 exhibited a reduced capacity to deplete the DPPH radical, which has a more sterically hindered radical site compared with ABTS, with 25 μM mdivi-1 displaying only 0.8 μM Trolox equivalency. Both assays indicate that mdivi-1 possesses biochemical antioxidant activity but with modest potency relative to the vitamin E analog Trolox. Future studies are needed to evaluate whether the ability of mdivi-1 to directly scavenge free radicals contributes to its mechanisms of neuroprotection. MDPI 2022-02-24 /pmc/articles/PMC8944504/ /pubmed/35326100 http://dx.doi.org/10.3390/antiox11030450 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Bordt, Evan A. Zhang, Naibo Waddell, Jaylyn Polster, Brian M. The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant Activity |
title | The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant Activity |
title_full | The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant Activity |
title_fullStr | The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant Activity |
title_full_unstemmed | The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant Activity |
title_short | The Non-Specific Drp1 Inhibitor Mdivi-1 Has Modest Biochemical Antioxidant Activity |
title_sort | non-specific drp1 inhibitor mdivi-1 has modest biochemical antioxidant activity |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944504/ https://www.ncbi.nlm.nih.gov/pubmed/35326100 http://dx.doi.org/10.3390/antiox11030450 |
work_keys_str_mv | AT bordtevana thenonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity AT zhangnaibo thenonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity AT waddelljaylyn thenonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity AT polsterbrianm thenonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity AT bordtevana nonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity AT zhangnaibo nonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity AT waddelljaylyn nonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity AT polsterbrianm nonspecificdrp1inhibitormdivi1hasmodestbiochemicalantioxidantactivity |